**Advanced Therapy (ATMP) projects often fail from poor decision-making, not weak science. FRESCI tackles this bottleneck by structuring uncertainty, aligning evidence with strategic goals, and applying proactive regulatory science. Our focus: smarter decisions and clear thinking to navigate ATMP complexity and translate scientific potential into approved, accessible therapies.

In today’s fast-evolving biotech and medtech landscape, businesses face unprecedented challenges. Navigating complex regulatory environments, accelerating technology readiness levels (TRL), and translating scientific discoveries into impactful health solutions require more than traditional approaches. This is where innovative consulting strategies come into play. By integrating evidence-based insights, AI-powered intelligence, and regulatory expertise, companies can transform

The Imperative of Market Viability/Economic sustainability In the rapidly evolving field of scientific research, particularly in...

In the ever-evolving field of health research, there lies a complex interplay between technological standardization, market acceptance,...